News

CPI-300 is a new, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL(R). IntelGenx’s development partner, Cary Pharma, serves as the NDA applicant for CPI-300. The

As per the agreement, AnaptysBio is likely to be responsible for generating new antibodies to a specified disease target, using its proprietary somatic hypermutation (SHM) technology platform. Merck

Earlier, in 2009, GSK entered into strategic collaborations with two specialist companies, Prosensa and JCR Pharmaceuticals. The alliance with Prosensa, announced in October 2009, focuses on nucleic acid-based

Carmot is expected to use the FBLD technology, called ‘Chemotype Evolution,’ for identifying drug candidates in a broad range of therapeutic areas, including inflammatory, metabolic, and neurodegenerative diseases.

The company has provided a literature review supporting it’s belief that administration of exogenous testosterone at doses resulting in morning testosterone levels within the normal range, render a

The study and the ongoing Phase 3 trial in chronic kidney disease patients are directed toward fulfilling licensure requirements in the US, Canada and Europe. Heplisav has been

Tramadol/APAP is a centrally-acting analgesic indicated for the short-term management of moderately severe acute pain. The product is designated as a controlled substance in some states. Amneal began

The company’s Hafnarfjordur facility in Iceland is a manufacturing site which exports 95% of its products. After expansion, the SOD-site‘s capacity will increase to 1.5 billion tablets per

The company said that as a late Phase 2 oncology product, Tesetaxel is the leading oral taxane currently in clinical development. Unlike standard Taxanes (paclitaxel [Taxol] or Docetaxel